| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.983 | 8.288 | 7.274 | 2.149 | 2.386 | 879 | 4.124 | 6.961 | 6.296 | 11.606 |
| Total Income - EUR | 4.983 | 8.288 | 7.274 | 2.149 | 2.386 | 18.617 | 4.124 | 8.948 | 6.341 | 11.606 |
| Total Expenses - EUR | 1.460 | 2.040 | 4.743 | 2.078 | 1.093 | 20.811 | 4.142 | 8.138 | 3.953 | 7.829 |
| Gross Profit/Loss - EUR | 3.524 | 6.248 | 2.532 | 71 | 1.293 | -2.195 | -19 | 809 | 2.387 | 3.777 |
| Net Profit/Loss - EUR | 3.374 | 6.000 | 2.459 | 49 | 1.250 | -2.753 | -141 | 576 | 2.013 | 3.175 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Anamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.325 | 13.890 | 12.334 | 12.663 | 12.393 | 10.736 | 8.673 | 3.349 | 2.606 | 1.862 |
| Current Assets | 948 | 2.119 | 1.992 | 2.038 | 3.243 | 71 | 1.793 | 1.404 | 346 | 4.059 |
| Inventories | 52 | 52 | -48 | 176 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 362 | 157 | -17 | 1.856 |
| Cash | 896 | 2.067 | 2.040 | 1.863 | 3.243 | 71 | 1.431 | 1.247 | 363 | 2.204 |
| Shareholders Funds | 6.993 | 12.921 | 14.061 | 14.637 | 12.864 | 9.867 | 9.507 | 4.637 | 6.636 | 9.774 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.280 | 3.088 | 265 | 65 | 2.772 | 939 | 960 | 116 | -3.684 | -3.852 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Anamed Srl